NFE2L2 and cancer: It was well known that KEAP1 functions as an adaptor for CUL3‐based E3 ligase to regulate proteasomal degradation of NFE2L2,38 the KEAP1/NFE2L2/CUL3 mutations caused the abnormal activation of the NFE2L2 pathway, which drive cancer progression.39